Legal & General Group PLC Reneo Pharmaceuticals, Inc. Transaction History

Legal & General Group PLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 15, 2024	BUY	$1.34 - $8.43 $372 - $2,343	278 Added 24.39%	1,418 $2,000
Q2 2023 Aug 14, 2023	BUY	$5.44 - $10.5 $6,201 - $11,970	1,140 New	1,140 $7,000
Q2 2022 Aug 22, 2022	SELL	$1.96 - $3.04 $1,372 - $2,128	-700 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$6.07 - $9.68 $880 - $1,403	145 Added 26.13%	700 $6,000
Q3 2021 Nov 15, 2021	SELL	$6.28 - $11.07 $985 - $1,737	-157 Reduced 22.05%	555 $4,000
Q2 2021 Aug 12, 2021	BUY	$7.78 - $15.0 $5,539 - $10,680	712 New	712 $7,000

31M

50.8K

Ticker RPHM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,479,600
Market Cap $41.1M
Description
Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development of therapies for patients with rare genetic mitochondrial diseases. It develops REN001, a selective peroxisome proliferator-activated receptor delta agonist, which is in Phase IIb clinical trial in patients with primary mitochondrial myopathies, as w...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.